Author:
Hang Nguyen TL,Ishizuka Naoki,Keicho Naoto,Hong Le T,Tam Do B,Thu Vu TX,Matsushita Ikumi,Harada Nobuyuki,Higuchi Kazue,Sakurada Shinsaku,Lien Luu T
Abstract
Abstract
Background
When a test for diagnosis of infectious diseases is introduced in a resource-limited setting, monitoring quality is a major concern. An optimized design of experiment and statistical models are required for this assessment.
Methods
Interferon-gamma release assay to detect tuberculosis (TB) infection from whole blood was tested in Hanoi, Viet Nam. Balanced incomplete block design (BIBD) was planned and fixed-effect models with heterogeneous error variance were used for analysis. In the first trial, the whole blood from 12 donors was incubated with nil, TB-specific antigens or mitogen. In 72 measurements, two laboratory members exchanged their roles in harvesting plasma and testing for interferon-gamma release using enzyme linked immunosorbent assay (ELISA) technique. After intervention including checkup of all steps and standard operation procedures, the second trial was implemented in a similar manner.
Results
The lack of precision in the first trial was clearly demonstrated. Large within-individual error was significantly affected by both harvester and ELISA operator, indicating that both of the steps had problems. After the intervention, overall within-individual error was significantly reduced (P < 0.0001) and error variance was no longer affected by laboratory personnel in charge, indicating that a marked improvement could be objectively observed.
Conclusion
BIBD and analysis of fixed-effect models with heterogeneous variance are suitable and useful for objective and individualized assessment of proficiency in a multistep diagnostic test for infectious diseases in a resource-constrained laboratory. The action plan based on our findings would be worth considering when monitoring for internal quality control is difficult on site.
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Westgard JO: Basic Planning for Quality. 2000, Madison: Westgard QC Inc
2. Kazmierczak SC: Laboratory quality control: using patient data to assess analytical performance. Clin Chem Lab Med. 2003, 41: 617-27. 10.1515/CCLM.2003.093.
3. Westgard JO, Barry PL, Hunt MR, Groth T: A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem. 1981, 27: 493-501.
4. Heuck CC, Deom A: Healthcare in the developing world: Need for appropriate laboratory technology. Clin Chem. 1991, 37: 490-6.
5. Smith PG, Morrow RH: Field trials of health interventions in developing countries: A toolbox. 1996, Oxford: Macmillan Press Limited, 2
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献